entity

Α-SYNUCLEIN PATHOLOGY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Α-SYNUCLEIN PATHOLOGY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

10Connections
0Hypotheses
1Analyses
1Outgoing
9Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
DOPAMINERGIC NEURONS IN SUBSTANTIA NIGRAassociated_withcell_type0.90

Incoming (9)

SourceRelationTypeStr
C3/C3aR Pathwaymodulatespathway0.90
41390672were reduced in relation topaper0.90
Microglia Depletionprotects_againstmechanism0.88
LAG3suppressesprotein0.85
GLUCOSYLCERAMIDASEregulatesenzyme0.85

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Can retromer-stabilizing compounds like R55 prevent neurodegeneration in vivo?

neurodegeneration | 2026-04-26 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

Can retromer-stabilizing compounds like R55 prevent neurodegeneration in vivo?

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Related Research

Hypotheses and analyses mentioning Α-SYNUCLEIN PATHOLOGY in their description or question text

No additional research found